Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis
Cha, D.-H.; Ajani, A.E.; Cheneau, E.; Waksman, R.
Journal of Invasive Cardiology 14(7): 432-437
2002
ISSN/ISBN: 1042-3931 PMID: 12082202 Document Number: 544718
The only gamma emitter used in clinical trials for in-stent restenosis is 192Iridium (192Ir). The efficacy of intracoronary gamma radiation therapy in reducing clinical and angiographic restenosis in patients with in-stent restenosis has been established. This review is intended to give an overview of the clinical trials utilizing gamma vascular brachytherapy in patients with in-stent restenosis and give insight into the future of intracoronary radiation therapy.
Document emailed within 1 workday
Related Documents
Bernardi, G. 2001: Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 2(5): 559-562Gruberg, L.; Beyar, R. 2003: Intracoronary radiation for in-stent restenosis in long lesions: too much, too little, too late? Journal of Invasive Cardiology 15(11): 644-645
Strnad, V. 2002: Intracoronary gamma brachytherapy significantly lowers the restenosis rate after PTCA and stent implantation Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 178(1): 51
Zimarino, M.; Ajani, A.E.; Marazia, S.; Pichard, A.D.; Satler, L.F.; De Caterina, R.; Barsotti, A.; Waksman, R. 2002: Influence of device selection on angiographic outcomes for the treatment of in-stent restenosis. A sub analysis from the Washington Radiation for In-Stent restenosis Trial (WRIST) Italian heart journal: official journal of the Italian Federation of Cardiology 3(4): 256-262
Sabaté, M.; Kay, I.P.; Gijzel, A.L.; Wardeh, A.J.; Van der Giessen, W.J.; Coen, V.L.; Ligthart, J.M.; Costa, M.A.; Kozuma, K.; Serrano, P.; Levendag, P.C.; Serruys, P.W. 1999: Compassionate use of intracoronary beta-irradiation for treatment of recurrent in-stent restenosis Journal of Invasive Cardiology 11(9): 582-588
Lee, M.S.; Pessegueiro, A.; Zimmer, R.; Jurewitz, D.; Tobis, J. 2008: Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era Journal of Invasive Cardiology 20(8): 401-403
Teirstein, P.S.; Massullo, V.; Jani, S.; Tripuraneni, P. 2001: Radiation therapy to inhibit restenosis: early clinical results Mount Sinai Journal of Medicine new York 68(3): 192-196
Lanjewar, C.P.; Sharma, A.; Sheth, T. 2009: IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent) Journal of Invasive Cardiology 21(5): E87-E90
Agrawal, S.K.; Macander, P.J.; Cannon, A.D.; Roubin, G.S. 1991: The Gianturco-Roubin flexible intracoronary stent: clinical application and initial results Indian Heart Journal 43(6): 403-413
Paranandi, S.N.; Topol, E.J. 1994: Contemporary clinical trials of restenosis Journal of Invasive Cardiology 6(4): 109-124
Waksman, R. 1996: Radiation catheter-based therapy for prevention of restenosis Cardiologia 41(9): 849-854
Rivard, M.J.; Zinkin, H.D.; Mignano, J.E.; Kimmelstiel, C.D. 2004: Treatment of in-stent restenosis for saphenous vein grafts using intravascular brachytherapy: regulatory challenges and clinical application Journal of Invasive Cardiology 16(2): 96
Jin, Z.-N.; Chen, Y.-D.; Lü, S.-Z.; Song, X.-T.; Zhu, H.-G.; Li, H. 2006: Clinical and angiographic predictors of restenosis after bare metal stent deployment in coronary artery disease patients complicated with diabetes Zhonghua Xin Xue Guan Bing Za Zhi 34(12): 1093-1096
Azzarelli, S.; Amico, F.; Galassi, A.R.; Giacoppo, M.; Argentino, V.; Fiscella, A. 2008: Two-year clinical follow up of coronary drug-eluting stent in patients at high risk for coronary restenosis Journal of Invasive Cardiology 20(2): 62-66
Rodriguez, A.E.; Alemparte, M.Rodriguez.; Vigo, C.F.; Pereira, C.Fernandez.; Llaurado, C.; Russo, M.; Virmani, R.; Ambrose, J.A. 2003: Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial) Journal of Invasive Cardiology 15(10): 581-584
Chen, W-Hong.; Kaul, U.; Leung, S-Kin.; Lau, Y-Kong.; Tan, H-Cheem.; Leung, A.Wai-Suen.; Lee, M.Kang-Yin.; Li, S-Kin.; Ng, W.; Lee, P-Yin.; Lam, K-Fai.; Tse, H-Fat.; Lau, C-Pak. 2005: A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial Journal of Invasive Cardiology 17(10): 534-538
Mahanonda, N.; Kangkagate, C.; Panchavinnin, P.; Tresukosol, D.; Sriyaphai, W.; Hongvisitagul, C.; Chirapastan, A.; Pinkaeo, S.; Chotinaiwattarakul, C.; Chaithiraphan, S. 1996: Experience of the first 60 cases of intracoronary stent placement Journal of the Medical Association of Thailand 79(11): 703-707
Ormiston, J.A.; Webster, M.W.I.; Ruygrok, P.N. 2002: Stent strut thickness and restenosis Circulation 105(2): E12
Elens, M.; Verbist, J.; Keirse, K.; Van Den Eynde, W.; Peeters, P. 2014: Which is currently the best strategy for treatment of SFA in-stent restenosis? Journal of Cardiovascular Surgery 55(4): 477-481
Denbow, C.E.; Chung, A.S.; Chung, E.E.; Coy, K.; Gist, H. 2001: Intracoronary stent implantation in Jamaica. The initial experience West Indian Medical Journal 50(1): 27-30